Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats.

[1]  R. Bodnar,et al.  Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV , 1999, Brain Research.

[2]  E. Tzavara,et al.  In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain Membranes , 1998 .

[3]  G. Pasternak,et al.  Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[4]  Z. Vogel,et al.  Interaction of agonist peptide [3H]Tyr-d-Ala-Phe-Phe-NH2 with μ-opioid receptor in rat brain and CHO-μ/1 cell line , 1998, Peptides.

[5]  A. Kastin,et al.  Endomorphin 1 and 2 Have Vasodepressor Activity in the Anesthetized Mouse , 1998, Peptides.

[6]  V. Hruby,et al.  Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor. , 1998, European journal of pharmacology.

[7]  D. Selley,et al.  Endomorphin‐Stimulated [35S]GTPγS Binding in Rat Brain: Evidence for Partial Agonist Activity at μ‐Opioid Receptors , 1998 .

[8]  A. Cavalli,et al.  mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. , 1998, Brain research. Molecular brain research.

[9]  Á. Díaz,et al.  Distinct inhibitory effects of spinal endomorphin‐1 and endomorphin‐2 on evoked dorsal horn neuronal responses in the rat , 1997, British journal of pharmacology.

[10]  L. Stone,et al.  Spinal analgesic actions of the new endogenous opioid peptides endomorphin‐1 and ‐2 , 1997, Neuroreport.

[11]  A. Kastin,et al.  The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. , 1997, Biochemical and biophysical research communications.

[12]  A. Kastin,et al.  A potent and selective endogenous agonist for the µ-opiate receptor , 1997, Nature.

[13]  G. Benedek,et al.  Mydriatic and antinociceptive effects of intrathecal dexmedetomidine in conscious rats. , 1994, European journal of pharmacology.

[14]  C. Stein,et al.  Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo , 1992, Neuroscience.

[15]  D. A. Thomas,et al.  Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. , 1991, European journal of pharmacology.

[16]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[17]  H. Kosterlitz,et al.  Species differences in the concentrations and distributions of opioid binding sites. , 1985, European journal of pharmacology.

[18]  T. Yaksh,et al.  Studies on the direct spinal action of narcotics in the production of analgesia in the rat. , 1977, The Journal of pharmacology and experimental therapeutics.

[19]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.